A

anti-IGF1 / 2 monoclonal antibody MEDI-573

A humanized monoclonal antibody directed against insulin-like growth factors 1 and 2 (IGF-1/2) with potential antineoplastic activity. Anti-IGF1/2 monoclonal … [Read more...]

anti-IGF1R recombinant monoclonal antibody MK-0646

A substance being studied in the treatment of many types of cancer. Anti-IGF1R recombinant monoclonal antibody MK-0646 binds to a protein called insulin-like … [Read more...]

anti-IL-1 alpha monoclonal antibody MABp1

A human IgG1 monoclonal antibody directed against interleukin-1 alpha (IL1a) with potential antineoplastic activity. Anti-IL-1 alpha monoclonal antibody MABp1 … [Read more...]

anti-IL-13 humanized monoclonal antibody TNX-650

A humanized monoclonal antibody directed against interleukin-13 (IL-13) with potential antineoplastic activity. Anti-IL-13 humanized monoclonal antibody TNX-650 … [Read more...]

anti-IL-6 chimeric monoclonal antibody

A human-mouse chimeric antibody, constructed from a murine antiinterleukin 6 (IL-6) monoclonal antibody, with antitumor and antiinflammatory activities. … [Read more...]

anti-inflammatory

Having to do with reducing inflammation. … [Read more...]

anti-integrin monoclonal antibody-DM4 immunoconjugate IMGN388

An immunoconjugate consisting of an anti-integrin monoclonal antibody covalently attached to the maytansinoid DM4, a derivative of the cytotoxic agent … [Read more...]

anti-interleukin 6 monoclonal antibody ALD518

A humanized monoclonal antibody directed against the pro-inflammatory cytokine interleukin-6 (Il-6) with potential immunomodulating activity. Upon … [Read more...]

anti-KIR monoclonal antibody IHP 2101

A human monoclonal antibody directed against the human inhibitory killer IgG-like receptor (KIR) with potential immunostimulating and antineoplastic activities. … [Read more...]

Anti-M-CSF monoclonal antibody MCS110

A humanized monoclonal antibody directed against macrophage colony-stimulating factor (M-CSF) with potential anti-osteolytic activity. Anti-M-CSF monoclonal … [Read more...]